Cell free DNA (cfDNA) analysis for the purpose of diagnostics is currently practiced for non-invasive prenatal screening of cell free fetal DNA (cffDNA), and is anticipated to be leveraged for early ...
Preeclampsia is a dangerous complication during pregnancy that endangers both the mother and fetus, but clinicians still don't have an effective way of predicting who will develop it. New research has ...
Analysis of cell-free fetal DNA (cffDNA) from maternal plasma to screen for elevated risk for trisomies 21 and 18 is as useful in a general obstetric population as it is in high-risk pregnancies, ...
The introduction of noninvasive cell-free fetal DNA (cffDNA) testing to detect fetal Down syndrome, and several other aneuploidy syndromes, signals a major shift in prenatal screening and diagnostic ...
Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...
Cell-free fetal DNA (cffDNA) in the supernatant of amniotic fluid, which is usually discarded, can be used as a sample for prenatal diagnosis. For rapid prenatal diagnosis of frequent chromosome ...
NEWARK, Del, March 10, 2025 (GLOBE NEWSWIRE) -- The global cell-free fetal DNA testing market is poised for steady growth, projected to reach USD 1,687.8 million by 2025 and expanding at a CAGR of 6.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results